Safety of combination therapy of robot suit HAL and repeptive transcranial magnetic stimulation for freezing gait of Parkinson disease

YAMANAKA Yoshitaka0 个研究点目标入组 5 人开始时间: 2022年10月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patient who meet all of the following conditinons are targeted
•1) Yahr classification: 2-4 Parkinson syndrome patients
•2) Patients whose freezing gait do not improve even after using a sufficient amount of anti-Parkinson's disease drug
•3)Patients aged over 20 under 80 at the time of informed consent
•4)Patients who can consent to appropriate contraception for the duration of the study
•5)Patients who have received sufficient explanation in participating in this study, and who have obtained written consent at their own free will with sufficient understanding.

•patient who meet any of the following condition are not eligible
•1) Patients who received a new start or increased dose of anti-PD drug within 12 weeks
•2) Patients with other diseases such as occupied lesions on the head image
•3) Cases in which rTMS is contraindicated in the guidelines on the safety of magnetic stimulation (2019 edition)
•4)Patient who are considered difficult to train with HAL
•5) Patients who are pregnant, may become pregnant, within 28 days after giving birth, or are breastfeeding
•6) In addition, patients who are judged by the investigator or the investigator to be inappropriate for conducting this study safely.

发起方

YAMANAKA Yoshitaka